Clinical Trial Update: Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis [Phase 1]

View source ↗

Summary

This is a Phase 1 pharmacokinetics study evaluating how oral treprostinil is processed in patients with systemic sclerosis. It assesses absorption, distribution…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Oral treprostinil (treprostinil)

Snippet

Sponsor: United Therapeutics | Conditions: Systemic Sclerosis | Phase 1 | Status: COMPLETED